Events
2018 budget: a tax update for biotech and tech businesses
Invitation to the essential 2018 post-budget briefing and general tax update for biotech and tech companies a free event We’ll keep it brief as you’re all busy but we’ll distill the significant bits of Chancellor Philip Hammond’s budget and discuss how they relate to biotech and tech businesses. The Confluence Tax team will be…
Read MoreAutumn 2017 post-budget tax briefing
You are invited… to the essential Autumn 2017 post-budget tax briefing for biotech and tech companies Key points distilled, digested and presented by the tax experts at Confluence Tax – we’ve done the hard work for you! We would be delighted if you could join us on November 23, 2017 in the Cambridge Building, Babraham…
Read MoreLife Sciences Structured M&A: seminar Confluence Tax, Dechert, SRS
ON MAY 3 Confluence Tax will be jointly running a seminar on biotech M&A transactions, taking place in London. Structured deals are a key feature of Life Sciences M&A transactions based on the principle of shared risk. These involve significant contingent consideration payable to selling shareholders based on clinical, regulatory and/or sales based milestones. How you negotiate…
Read MoreTax in Switzerland vs UK tax systems: no comparison?
WHEN I received the invitation to attend the UK BioIndustry Association’s biotech fact-finding mission to Switzerland to see how the biotech sector might interact in a post-EU UK, I was intrigued to see how it could work for tax. If you indulge in lazy comparisons then you could muse on whether a devolved UK of England, Scotland,…
Read MoreTax discovery mission to Switzerland with BIA
Travel is fatal to prejudice. When doing comparative summaries of tax systems around the world, Switzerland is always the awkward territory. The Swiss have both a federal and a cantonal (local) system of tax, and each tax liability is deductible from the other, resulting in impossible calculations. The tax rate is also somewhat negotiable. All…
Read More